IL76889A0 - Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same - Google Patents
Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL76889A0 IL76889A0 IL76889A IL7688985A IL76889A0 IL 76889 A0 IL76889 A0 IL 76889A0 IL 76889 A IL76889 A IL 76889A IL 7688985 A IL7688985 A IL 7688985A IL 76889 A0 IL76889 A0 IL 76889A0
- Authority
- IL
- Israel
- Prior art keywords
- solubilised
- production
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003058 platinum compounds Chemical class 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848427767A GB8427767D0 (en) | 1984-11-02 | 1984-11-02 | Solubilised platinum compound |
GB848429030A GB8429030D0 (en) | 1984-11-16 | 1984-11-16 | Solubilised platinum compound |
GB858503432A GB8503432D0 (en) | 1985-02-11 | 1985-02-11 | Solubilised platinum compound |
Publications (1)
Publication Number | Publication Date |
---|---|
IL76889A0 true IL76889A0 (en) | 1986-02-28 |
Family
ID=27262501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL76889A IL76889A0 (en) | 1984-11-02 | 1985-10-31 | Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same |
Country Status (10)
Country | Link |
---|---|
US (1) | US4696918A (es) |
EP (1) | EP0181166A3 (es) |
KR (1) | KR860003830A (es) |
AU (1) | AU4931985A (es) |
DK (1) | DK500185A (es) |
ES (1) | ES8801168A1 (es) |
FI (1) | FI854301A (es) |
GR (1) | GR852655B (es) |
HU (1) | HUT40677A (es) |
IL (1) | IL76889A0 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
CS269719B1 (en) * | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
US4956459A (en) * | 1987-07-17 | 1990-09-11 | Georgetown University | Platinum compounds suitable for use as pharmaceuticals |
JPH01146826A (ja) * | 1987-12-03 | 1989-06-08 | Nippon Kayaku Co Ltd | 白金化合物の凍結乾燥製剤 |
EP0324154B1 (de) * | 1988-01-09 | 1993-03-17 | ASTA Medica Aktiengesellschaft | 1,2-Bis(aminomethyl)cyclobutan-Platin-Komplexe |
US5132385A (en) * | 1990-12-14 | 1992-07-21 | General Electric Company | One part heat curable organopolysiloxane compositions |
US5300280A (en) * | 1992-02-14 | 1994-04-05 | Mallinckrodt Medical, Inc. | Stabilized radiopharmaceutical kits |
KR100351707B1 (ko) * | 1994-12-30 | 2002-11-02 | 에스케이케미칼주식회사 | 플라티늄(II)착화합물과히드록시프로필β-사이클로덱스트린의복합체 |
CN1121380C (zh) * | 2000-03-03 | 2003-09-17 | 北京兴大豪斯科技有限公司 | 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物 |
AUPQ641100A0 (en) * | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
WO2005102312A1 (en) * | 2004-04-27 | 2005-11-03 | Mayne Pharma Limited | Concentrated oxaliplatin solutions |
CZ2004964A3 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
DE102005047308A1 (de) * | 2005-09-30 | 2007-04-05 | Martin-Luther-Universität Halle-Wittenberg | Platin(II)Verbindungen aus 2-substituierten Propan-1,3-diaminen zur Verwendung als Chemotherapeutikum |
EP1954292B1 (en) * | 2005-11-28 | 2014-05-07 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing nephrotoxicity and methods of use thereof |
US7658913B2 (en) * | 2005-11-28 | 2010-02-09 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing nephrotoxicity and methods of use thereof |
CZ300120B6 (cs) * | 2006-06-20 | 2009-02-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
FR2989001B1 (fr) * | 2012-04-06 | 2017-07-21 | Centre Nat Rech Scient | Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2959580A (en) * | 1956-10-17 | 1960-11-08 | Univ Minnesota | Formation of inclusion compounds |
GB978485A (en) * | 1960-10-26 | 1964-12-23 | Astra Apotekarnes Kem Fab | Iron preparations for intramuscular injection |
US3821192A (en) * | 1971-08-18 | 1974-06-28 | Central Pharmacal Co | Process for preparing an iron-saccharide complex |
CH605550A5 (es) * | 1972-06-08 | 1978-09-29 | Research Corp | |
DE2260536C3 (de) * | 1972-12-11 | 1975-07-10 | Fa. H. Trommsdorff, 5100 Aachen | MolekiileinschluBverbindungen aus einem Silberalkanolammin-Komplex und beta-Cycloheptaamylose, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
US4234499A (en) * | 1979-03-07 | 1980-11-18 | Engelhard Minerals & Chemicals Corporation | Cis-diammireplatinum(II) organophosphate complexes |
JPS57123198A (en) * | 1981-01-23 | 1982-07-31 | Shionogi & Co Ltd | Novel platinum complex |
HU183430B (en) * | 1981-05-12 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride |
JPS5921697A (ja) * | 1982-06-24 | 1984-02-03 | Yoshinori Kitani | 新規な白金錯体 |
US4500465A (en) * | 1982-06-28 | 1985-02-19 | Engelhard Corporation | Solubilized platinum (II) complexes |
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
US4584392A (en) * | 1982-11-10 | 1986-04-22 | Inco Alloys International, Inc. | Platinum and palladium complexes |
US4565884A (en) * | 1983-05-10 | 1986-01-21 | Andrulis Research Corporation | Bis-platinum complexes as antitumor agents |
US4587331A (en) * | 1984-12-17 | 1986-05-06 | American Cyanamid Company | Platinum complexes of polyhydroxylated alkylamines and 2-polyhydroxylated alkyl-1,2-diaminoethanes |
-
1985
- 1985-10-31 US US06/793,341 patent/US4696918A/en not_active Expired - Fee Related
- 1985-10-31 IL IL76889A patent/IL76889A0/xx unknown
- 1985-10-31 DK DK500185A patent/DK500185A/da not_active Application Discontinuation
- 1985-10-31 ES ES548424A patent/ES8801168A1/es not_active Expired
- 1985-11-01 FI FI854301A patent/FI854301A/fi not_active Application Discontinuation
- 1985-11-01 HU HU854207A patent/HUT40677A/hu unknown
- 1985-11-01 EP EP85307934A patent/EP0181166A3/en not_active Ceased
- 1985-11-02 KR KR1019850008170A patent/KR860003830A/ko not_active Application Discontinuation
- 1985-11-04 GR GR852655A patent/GR852655B/el unknown
- 1985-11-04 AU AU49319/85A patent/AU4931985A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK500185A (da) | 1986-05-03 |
HUT40677A (en) | 1987-01-28 |
US4696918A (en) | 1987-09-29 |
FI854301A (fi) | 1986-05-02 |
ES8801168A1 (es) | 1987-02-16 |
ES548424A0 (es) | 1987-02-16 |
AU4931985A (en) | 1986-05-08 |
EP0181166A3 (en) | 1987-07-29 |
FI854301A0 (fi) | 1985-11-01 |
GR852655B (es) | 1986-02-26 |
EP0181166A2 (en) | 1986-05-14 |
DK500185D0 (da) | 1985-10-31 |
KR860003830A (ko) | 1986-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA859756B (en) | Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same | |
IL75400A0 (en) | Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL75120A0 (en) | New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
DE3474446D1 (en) | Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production | |
LTIP1467A (en) | Tertiary hydroxyalkylxantines, process for the preparation thereof and pharmaceutical composition containing them | |
EP0161877A3 (en) | 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same | |
IL72085A0 (en) | 13alpha-alkylylgonanes,processes for their preparation and pharmaceutical compositions containing the same | |
EP0157346A3 (en) | Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same | |
IL65167A (en) | N-acyl-polypeptides,their production and pharmaceutical compositions containing them | |
IL64345A (en) | Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same | |
IL76889A0 (en) | Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same | |
IL63801A (en) | 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)-pyridine-maleate,its production and pharmaceutical compositions containing it | |
IL74043A (en) | 8alhpa-acylaminoergolines,their production and pharmaceutical compositions containing them | |
GR80730B (en) | 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use | |
IL76327A (en) | Phenylacetonitrile derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
GB2169291B (en) | 8a-acylaminoergolines, their production and pharmaceutical compositions containing them | |
SG22688G (en) | 3-3-dialkyl-and, 3,3-alkylene-indoline derivatives, processes for their production and pharmaceutical compositions comprising them | |
IL79542A0 (en) | 3,7-disubstituted-3-cephem derivatives,processes for the production thereof and pharmaceutical compositions containing the same | |
IL74388A0 (en) | Diazepinoindoles,their production and pharmaceutical compositions containing them | |
ZA853375B (en) | New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
DE3562370D1 (en) | Amide compounds, process for preparing the same and pharmaceutical compositions containing the same | |
ZA852554B (en) | Novel substituted benzodioxole derivatives,processes for their manufacture and corresponding pharmaceutical compositions | |
IL73586A0 (en) | Pyrimidoisoquinoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL74207A0 (en) | Pteridine derivatives,process for the preparation thereof,and pharmaceutical compositions containing the same | |
EP0178076A3 (en) | Organo-silicone compounds, process for their manufacture, and pharmaceutical compositions thereof |